EFDID: 455154EFD: View Filing

Issuer: Enveric Biosciences, Inc. (0000890821) - D

Accession: 0000890821-22-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0000890821
  • Entity Name:
    Enveric Biosciences, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    4851 TAMIAMI TRAIL N, SUITE 200
    NAPLES, FL 34103
  • Persons:
    Related Persons 13
    Joseph Tucker, PhD
    Executive Officer, Director 
    Chief Executive Officer and Director
    David Johnson
    Executive Officer, Director 
    Chairman
    Carter Ward
    Executive Officer 
    Chief Financial Officer
    Avani Kanubaddi
    Executive Officer 
    President and Chief Operating Officer
    George Kegler
    Director
    Sol Mayer
    Director
    Dr. Bob Dagher
    Executive Officer 
    Chief Medical Officer
    Peter Facchini, PhD
    Executive Officer 
    Chief Innovation Officer
    Dr. Douglas Lind
    Director
    Dr. Marcus Schabacker
    Director
    Frank Pasqualone
    Director
    Bevin O'Niel
    Director
    Michael D. Webb
    Director
EDGAR: Offering Information
  • Accession Date:
    08/05/2022
  • First Sale Date:
    07/22/2022
  • Offering Amount:
    $8,617,500
  • Amount Sold:
    $8,617,500
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    Includes 625K shares (or pre-funded warrants) and warrants to buy up to 625K shares at $8.00 per share and warrant for 1 share; warrants to buy up to 375K shares exercise price $7.78/share; 70K placement agent warrants, exercise price $10.00/share.
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:NY
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
H.C. Wainwright & Co., LLC 375 None None FL, NY
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Enveric Biosciences, Inc.Carter WardCarter WardChief Financial Officer2022-08-05
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Apr. 19, 2023 455154: 0001493152-23-012905 Enveric Biosciences, Inc.
Offer Amount: $12,780,000
Amount Sold: $12,780,000
D Aug. 05, 2022 455154: 0000890821-22-000001 Enveric Biosciences, Inc.
Offer Amount: $8,617,500
Amount Sold: $8,617,500